Basal-Bolus Insulin Therapy with Gla-300 During Hospitalization Reduces Nocturnal Hypoglycemia in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Study.

about

Basal-Bolus Insulin Therapy with Gla-300 During Hospitalization Reduces Nocturnal Hypoglycemia in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Study.

Item

http://www.wikidata.org/entity/Q55078513

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Basal-Bolus Insulin Therapy wi ...... A Randomized Controlled Study.

@en

Basal-Bolus Insulin Therapy wi ...... A Randomized Controlled Study.

@nl

type

Item

label

Basal-Bolus Insulin Therapy wi ...... A Randomized Controlled Study.

@en

Basal-Bolus Insulin Therapy wi ...... A Randomized Controlled Study.

@nl

prefLabel

Basal-Bolus Insulin Therapy wi ...... A Randomized Controlled Study.

@en

Basal-Bolus Insulin Therapy wi ...... A Randomized Controlled Study.

@nl

P1476

Basal-Bolus Insulin Therapy wi ...... A Randomized Controlled Study

@en

P2093

Hitoshi Sugihara

http://www.w3.org/2001/XMLSchema#string

Katsuhito Kato

http://www.w3.org/2001/XMLSchema#string

Naoya Emoto

http://www.w3.org/2001/XMLSchema#string

Yuji Yamaguchi

http://www.w3.org/2001/XMLSchema#string

Yuki Shuto

http://www.w3.org/2001/XMLSchema#string

Yuko Nakamura

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and safety of HOE 901 versus NPH insulin in patients with type 1 diabetes. The European Study Group of HOE 901 in type 1 diabetes.

The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study

Investigational new insulin glargine 300 U/ml has the same metabolism as insulin glargine 100 U/ml.

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

Single-dose new insulin glargine 300 U/ml provides prolonged, stable glycaemic control in Japanese and European people with type 1 diabetes.

New insulin glargine 300 units/mL versus glargine 100 units/mL in people with type 2 diabetes using oral agents and basal insulin: glucose control and hypoglycemia in a 6-month randomized controlled trial (EDITION 2).

New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin-naïve people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (EDITION 3).

Continuous Glucose Monitoring During Basal-Bolus Therapy Using Insulin Glargine 300 U mL(-1) and Glargine 100 U mL (-1) in Japanese People with Type 1 Diabetes Mellitus: A Crossover Pilot Study.

Autonomic cardiac regulation during spontaneous nocturnal hypoglycemia in patients with type 1 diabetes.

One-year sustained glycaemic control and less hypoglycaemia with new insulin glargine 300 U/ml compared with 100 U/ml in people with type 2 diabetes using basal plus meal-time insulin: the EDITION 1 12-month randomized trial, including 6-month exten

P2888

s13300-018-0419-z

P304

1049-1059

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13300-018-0419-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Fumitaka Okajima

P577

2018-04-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1103158197

http://www.w3.org/2001/XMLSchema#string

P698

29619751

http://www.w3.org/2001/XMLSchema#string

P921

hypoglycemia

hospitalization

P932

5984922

http://www.w3.org/2001/XMLSchema#string